Pediatrics

Latest News

FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis
FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis

April 29th 2024

The acceptance is based on positive data from the phase 3 ADORING 1 and ADORING 2 pivotal trials, as well as interim results from the phase 3 ADORING 3 open-label, long-term extension trial.

cannabis background | Image Credit: yellowj - stock.adobe.com
Recreational Cannabis Legalization Associated with Decreases in Alcohol, E-Cigarette Use

April 29th 2024

FDA approval seal -- Image credit: Aquir | stock.adobe.com
FDA Approves Mavorixafor Capsules to Treat Patients With WHIM Syndrome

April 29th 2024

FDA approval stamp -- Image credit: Olivier Le Moal | stock.adobe.com
FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors

April 23rd 2024

FDA approval seal -- Image credit: Aquir | stock.adobe.com
FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

April 8th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.